Profil
Robert Hedequist is currently the President & Chief Operating Officer at Kineta Chronic Pain LLC and Kineta Immuno-Oncology LLC.
He previously worked as a Director at Kv1.3 Therapeutics, Inc. and as the President & Chief Operating Officer at Kineta, Inc. (Washington).
Aktive Positionen von Robert Hedequist
| Unternehmen | Position | Beginn |
|---|---|---|
Kineta Immuno-Oncology LLC
Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Operates as biotechnology company, which develops disruptive technologies that shift the paradigm in cancer treatment by turning cold tumors hot | Präsident | - |
Ehemalige bekannte Positionen von Robert Hedequist
| Unternehmen | Position | Ende |
|---|---|---|
Kineta Chronic Pain LLC
Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Präsident | 13.03.2025 |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kineta Chronic Pain LLC
Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Health Technology |
Kineta Immuno-Oncology LLC
Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Operates as biotechnology company, which develops disruptive technologies that shift the paradigm in cancer treatment by turning cold tumors hot | Health Technology |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
















